Don't expect pot stocks to deliver the green anytime soon.
News & Analysis: Charlotte's Web
The Food and Drug Administration's consumer update on cannabidiol might appear damning, but investors can still profit from CBD's growth.
Two recent developments have heightened investors' anxiety about the CBD stock. Are the worries overblown?
CBD might not be as safe as many thought, claims the FDA.
The Food and Drug Administration cautions that "CBD has the potential to harm you" in a newly released consumer update.
The U.S. health industry regulator sounds numerous alarm bells about the popular substance found in cannabis.
A major milestone toward legalizing cannabis in the U.S. fueled a big gain for the CBD stock.
The hemp stock's struggles continue to get even worse.
CWBHF earnings call for the period ending September 30, 2019.
It could take years for the Food and Drug Administration to produce a regulatory framework for CBD.